Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease
- 1 July 2011
- journal article
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 239 (1), 129-135
- https://doi.org/10.2460/javma.239.1.129
Abstract
Objective—To determine associations between in vitro minimum inhibitory concentrations (MICs) of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with clinical signs of bovine respiratory disease (BRD). Design—Observational, retrospective, cohort study. Animals—976 feeder calves with clinical signs of BRD enrolled in 16 randomized clinical trials. Procedures—Records of clinical trials from October 26, 1996, to November 15, 2004, were searched to identify calves with BRD from which a single isolate of M haemolytica or P multocida was identified via culture of deep nasal swab samples prior to treatment with tilmicosin (10 mg/kg [4.5 mg/lb], SC) and for which MICs of tilmicosin against the isolate were determined. The MICs of tilmicosin against recovered isolates and response to tilmicosin treatment were evaluated. Results—Tilmicosin resistance among M haemolytica and P multocida isolates was uncommon (6/745 [0.8%] and 16/231 [6.9%], respectively). Treatment outcome, defined as success or failure after tilmicosin treatment, did not vary with the MIC of tilmicosin against recovered isolates. The proportion of treatment failures attributed to M haemolytica isolates categorized as resistant (MIC of tilmicosin, ≥ 32 μg/mL) or not susceptible (MIC of tilmicosin, ≥ 16 μg/mL), was 0.2% and 0.5%, respectively. Conclusions and Clinical Relevance—Recovery of tilmicosin-resistant M haemolytica or P multocida isolates was rare, and no association was detected between MIC of tilmicosin and treatment response.Keywords
This publication has 10 references indexed in Scilit:
- Relationship between results of in vitro susceptibility tests and outcomes following treatment with pirlimycin hydrochloride in cows with subclinical mastitis associated with gram-positive pathogensJournal of the American Veterinary Medical Association, 2009
- Isolation and Antimicrobial Susceptibilities of Bacterial Pathogens from Bovine Pneumonia: 1994–2002Journal of Veterinary Diagnostic Investigation, 2004
- Use of antimicrobial susceptibility testing of bacterial pathogens isolated from the milk of dairy cows with clinical mastitis to predict response to treatment with cephapirin and oxytetracyclineJournal of the American Veterinary Medical Association, 2002
- Effects of tilmicosin treatment on Pasteurella haemolytica organisms in nasal secretion specimens of calves with respiratory tract diseaseAmerican Journal of Veterinary Research, 2000
- Use and misuse of population attributable fractions.American Journal of Public Health, 1998
- Economic Impact Associated with Respiratory Disease in Beef CattleVeterinary Clinics of North America: Food Animal Practice, 1997
- Antimicrobial Therapy of Bovine Respiratory DiseaseVeterinary Clinics of North America: Food Animal Practice, 1997
- Bacterial PneumoniaVeterinary Clinics of North America: Food Animal Practice, 1997
- Minimum Inhibitory Concentration Breakpoints and Disk Diffusion Inhibitory Zone Interpretive Criteria for Tilmicosin Susceptibility Testing against Pasteurella Spp. Associated with Bovine Respiratory DiseaseJournal of Veterinary Diagnostic Investigation, 1996
- Efficacy of tilmicosin in treatment of pulmonary infections in calvesVeterinary Record, 1991